These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31048687)

  • 1. Myasthenia gravis.
    Nat Rev Dis Primers; 2019 May; 5(1):31. PubMed ID: 31048687
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies.
    Rajakulendran S; Viegas S; Spillane J; Howard RS
    J Neurol; 2012 Dec; 259(12):2736-9. PubMed ID: 22955633
    [No Abstract]   [Full Text] [Related]  

  • 3. 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies.
    Evoli A; Alboini PE; Damato V; Iorio R
    Neurology; 2016 Mar; 86(11):1070-1. PubMed ID: 26873957
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.
    Morren J; Li Y
    Muscle Nerve; 2018 Sep; 58(3):344-358. PubMed ID: 29461627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
    Hain B; Hanisch F; Deschauer M
    Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis.
    Kirzinger L; Khomenko A; Schulte-Mattler W; Backhaus R; Platen S; Schalke B
    Pediatr Neurol; 2016 Dec; 65():90-92. PubMed ID: 27697312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-Specific Kinase Autoimmune Myasthenia Gravis: Report of a Pediatric Case and Literature Review.
    Ben Younes T; Benrhouma H; Klaa H; Ben Aoun R; Rouissi A; Ben Ahmed M; Kraoua I; Ben Youssef-Turki I
    Neuropediatrics; 2019 Apr; 50(2):116-121. PubMed ID: 30577044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-AChR, MuSK, and LRP4 antibodies coexistence: A rare and distinct subtype of myasthenia gravis from Indian subcontinent.
    Bokoliya SC; Kumar VP; Nashi S; Polavarapu K; Nalini A; Patil SA
    Clin Chim Acta; 2018 Nov; 486():34-35. PubMed ID: 30006288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia gravis].
    Kawaguchi N; Hattori T
    Nihon Rinsho; 2005 May; 63 Suppl 5():416-21. PubMed ID: 15954385
    [No Abstract]   [Full Text] [Related]  

  • 10. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemidiaphragm atrophy in muscle-specific kinase myasthenia gravis.
    Cartwright MS; Keskinyan VS
    Muscle Nerve; 2016 Aug; 54(2):338-9. PubMed ID: 26852898
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis.
    Gilhus NE; Tzartos S; Evoli A; Palace J; Burns TM; Verschuuren JJGM
    Nat Rev Dis Primers; 2019 May; 5(1):30. PubMed ID: 31048702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity.
    Bedlack RS; Simel DL; Bosworth H; Samsa G; Tucker-Lipscomb B; Sanders DB
    Neurology; 2005 Jun; 64(11):1968-70. PubMed ID: 15955957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's in the serum of seronegative MG and LEMS?: MuSK et al.
    Abicht A; Lochmüller H
    Neurology; 2002 Dec; 59(11):1672-3. PubMed ID: 12473750
    [No Abstract]   [Full Text] [Related]  

  • 15. MuSK antibody positive myasthenia gravis in a 38-year old West Indian female.
    Ramcharan K; Bahall M; Bodoe C; Khan S; Ewe P; Sharma S
    West Indian Med J; 2011 Dec; 60(6):694-5. PubMed ID: 22512235
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on laboratory diagnosis in myasthenia gravis.
    Oger J; Frykman H
    Clin Chim Acta; 2015 Sep; 449():43-8. PubMed ID: 26238187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis.
    Jordan B; Schilling S; Zierz S
    J Neurol; 2016 Jan; 263(1):174-6. PubMed ID: 26645394
    [No Abstract]   [Full Text] [Related]  

  • 19. Rethinking the utility of acetylcholine receptor antibody titer as a pharmacodynamic biomarker for myasthenia gravis.
    Lee I; Sanders D
    Muscle Nerve; 2021 Oct; 64(4):385-387. PubMed ID: 34287983
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment: Is 3,4-DAP a new option in treating MuSK MG?
    Hobson-Webb LD
    Neurology; 2016 Mar; 86(11):1071. PubMed ID: 26873955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.